| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.32B | 6.61B | 6.32B | 5.86B | 7.47B | 5.13B |
| Gross Profit | 2.66B | 2.50B | 2.66B | 2.43B | 4.17B | 2.27B |
| EBITDA | 2.89B | 3.97B | 3.30B | 2.85B | 4.73B | 2.63B |
| Net Income | 835.10M | 829.40M | 835.10M | 1.53B | 2.23B | 886.60M |
Balance Sheet | ||||||
| Total Assets | 19.65B | 22.63B | 19.65B | 18.24B | 17.28B | 16.60B |
| Cash, Cash Equivalents and Short-Term Investments | 3.38B | 4.32B | 3.38B | 2.39B | 3.71B | 3.67B |
| Total Debt | 4.08B | 5.35B | 4.08B | 3.27B | 3.17B | 3.75B |
| Total Liabilities | 7.60B | 9.68B | 7.60B | 6.59B | 6.25B | 6.52B |
| Stockholders Equity | 8.95B | 9.46B | 8.95B | 8.63B | 8.35B | 7.75B |
Cash Flow | ||||||
| Free Cash Flow | 203.80M | -129.30M | 203.80M | -2.30M | 1.89B | 751.30M |
| Operating Cash Flow | 2.33B | 2.29B | 2.33B | 1.88B | 3.67B | 2.06B |
| Investing Cash Flow | -2.09B | -2.08B | -2.09B | -477.50M | -2.20B | -2.19B |
| Financing Cash Flow | -402.00M | 1.35B | -402.00M | -1.33B | -1.95B | 717.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £262.75M | 9.44 | 9.97% | 5.72% | 5.70% | -9.60% | |
76 Outperform | $20.10B | 57.12 | 11.97% | 2.45% | 34.84% | 78.48% | |
76 Outperform | £950.12M | 15.11 | 15.06% | 0.82% | 23.97% | 216.41% | |
68 Neutral | £41.28B | -26.72 | -5.26% | 1.95% | -1.06% | -285.88% | |
63 Neutral | £26.25B | ― | ― | 709.22% | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | $30.82B | ― | -9.21% | 0.82% | -27.65% | -160.77% |